|
Market Closed -
Nasdaq
21:00:00 17/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2.910 USD | -3.64% |
|
-13.91% | -30.05% |
| Market Cap | 294M 266M 246M 222M 419M 27.43B 435M 2.97B 1.17B 14.8B 1.1B 1.08B 46.76B | P/E 2026 * |
-11.2x | P/E 2027 * | -18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 294M 266M 246M 222M 419M 27.43B 435M 2.97B 1.17B 14.8B 1.1B 1.08B 46.76B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
46.56% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GALT | Delayed | |
| GALT | Real-time | ||
| PHPN | Delayed | ||
| PHPN | Delayed | ||
| PHPN | Real-time | ||
| PHPN | Real-time |
Last Transcript: Galectin Therapeutics Inc.
| 1 day | -3.64% | ||
| 1 week | -13.91% | ||
| Current month | -12.35% | ||
| 1 month | -19.61% | ||
| 3 months | -17.09% | ||
| 6 months | +34.10% | ||
| Current year | -30.05% |
| 1 week | 2.82 | 3.53 | |
| 1 month | 2.82 | 3.73 | |
| Current year | 2.02 | 5.55 | |
| 1 year | 2.02 | 7.13 | |
| 3 years | 0.73 | 7.13 | |
| 5 years | 0.73 | 7.13 | |
| 10 years | 0.73 | 9.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joel Lewis
CEO | Chief Executive Officer | 56 | 01/09/2020 |
Jack Callicutt
DFI | Director of Finance/CFO | 58 | 30/06/2013 |
| Chief Tech/Sci/R&D Officer | - | 30/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilbert Amelio
BRD | Director/Board Member | 83 | 11/02/2009 |
Kevin Freeman
BRD | Director/Board Member | 65 | 30/04/2011 |
Harold Shlevin
BRD | Director/Board Member | 77 | 30/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/07/26 | Exercice | Chairman | 34,376,167 | 34.0866% | ||
| 14/07/26 | Exercice | Chief Technology Officer | 48,750 | 0.0483% | ||
| 29/06/26 | Exercice | Director | 66,804 | 0.1014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.64% | -13.91% | -51.50% | +48.47% | 294M | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 66.37B | ||
| +1.08% | -1.35% | +9.51% | +91.61% | 58.86B | ||
| +0.95% | +0.90% | +26.53% | +87.46% | 55.22B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 47.21B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 42.45B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.44B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 35.19B | ||
| +0.14% | -1.49% | +83.09% | +58.02% | 32.66B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.73B | ||
| Average | -0.66% | -2.35% | +26.72% | +160.23% | 40B | |
| Weighted average by Cap. | -0.08% | -2.18% | +35.09% | +147.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -20.9M -18.97M -17.53M -15.81M -29.85M -1.95B -30.99M -211M -83.53M -1.05B -78.41M -76.76M -3.33B | -16.8M -15.25M -14.09M -12.71M -23.99M -1.57B -24.91M -170M -67.14M -847M -63.03M -61.7M -2.68B |
| Net Debt | - | - |
Employees
9
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/11/26 | US$2.910 | -3.64% | 263,205 |
| 16/11/26 | US$3.020 | -0.98% | 231,994 |
| 13/11/26 | US$3.050 | -2.87% | 181,588 |
| 12/11/26 | US$3.140 | -4.56% | 226,411 |
| 11/11/26 | US$3.290 | -2.66% | 77,983 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.910USD
Average target price
11.00USD
Spread / Average Target
+278.01%
- Stock Market
- Stocks
- GALT Stock
Select your edition
All financial news and data tailored to specific country editions
















